Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists

Paul W. Harms(Michigan Medicine), Timothy L. Frankel(University of Michigan), Myrto Moutafi(Yale University), Arvind Rao(University of Michigan), David L. Rimm(Yale University), Janis M. Taube(Bloomberg (United States)), Dafydd Thomas(Michigan Medicine), May P. Chan(University of Michigan), Liron Pantanowitz(Michigan Medicine)

Modern Pathology

April 25, 2023

10.1016/j.modpat.2023.100197

Cited by 162Open Access

Abstract

Related Papers

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al.|New England Journal of Medicine|2012|12.6k

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley et al.|Nature|2014|6.6k

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz et al.|Nature|2014|5.3k

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al.|Journal of Thoracic Oncology|2016|1.2k

Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis

Edward C. Stack, Chichung Wang, Kristin Roman et al.|Methods|2014|783